ANDA 63116, held by Hospira. Tobramycin Sulfate.
As of Nov 16, 2026, ANDA 63116 (Tobramycin Sulfate (Pharmacy Bulk)), held by Hospira, was first approved by FDA on May 18, 1992, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 18, 1992 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tobramycin Sulfate (Pharmacy Bulk)EQ 40MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** ยท injectable;injection | Tobramycin Sulfate | Discontinued |
| Dec 8, 2011 | Supplement 10Labeling | Approved | |
| Oct 4, 2004 | Supplement 7Labeling | Approved | None posted |
| Oct 25, 2002 | Supplement 6Manufacturing | Approved | None posted |
| Feb 16, 1999 | Supplement 5Manufacturing | Approved | None posted |
| Oct 3, 1996 | Supplement 3Manufacturing | Approved | None posted |
| Aug 2, 1994 | Supplement 1Labeling | Approved | None posted |
| May 18, 1992 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters